Diagnio is a UAE-based HealthTech startup revolutionizing hormonal and fertility diagnostics for women.

Prioritizing women's experience, Diagnio offers innovative, digitally powered test systems to provide accurate insights into reproductive health in the comfort of one's home.

Globally, 30 million women struggle with fertility challenges annually. In the Gulf region, the infertility rate exceeds 40%. Yet, infertility is not considered a disease until 1 or 2 years of unsuccessful attempts, largely due to limited access to early screening.

Diagnio's mission addresses this gap, providing an accessible, cost-effective solution ensuring privacy, accurate diagnostics, and timely fertility issues detection.

Diagnio's first product - Smart Ovulation Test Kit – has the perfect combo to provide accurate insights into cycle phases and ovulation.

Diagnio Ovulation Microscope measures estrogen levels in a woman's saliva, while Diagnio App interprets the results, offers AI-powered personalized recommendations, and has features to assess infertility risk factors (stress and energy levels assessment, diabetes predisposition, etc.)

What sets Diagnio apart is its fusion of innovative technology with a profound understanding of women's challenges. Whether aiming for a desired pregnancy, navigating fertility treatments, or seeking deeper knowledge about their reproductive health, women can now take control, empowered with Diagnio's tools and unwavering support.